Anika Therapeutics reported $347.75M in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acorda Therapeutics ACOR:US USD 393.34M 12.97M
Agenus AGEN:US USD 429.02M 27.15M
Agios Pharmaceuticals AGIO:US USD 1.18B 72.15M
Anika Therapeutics ANIK:US USD 347.75M 6.38M
Arrowhead Research ARWR:US USD 691.94M 59.84M
Clovis Oncology CLVS:US USD 346.78M 46.08M
Enanta Pharmaceuticals ENTA:US USD 375.41M 9.8M
Halozyme Therapeutics HALO:US USD 1.86B 83.15M
Heron Therapeutics HRTX:US USD 271.95M 27.99M
Immunogen IMGN:US USD 358.8M 63.5M
Insmed INSM:US USD 994.82M 58.54M
Intrexon XON:US USD 259.24M 61.98M
Karyopharm Therapeutics KPTI:US USD 231.24M 25.24M
Ligand Pharmaceuticals LGND:US USD 1.05B 25.68M
Macrogenics MGNX:US USD 195.35M 22.7M
Merit Medical Systems MMSI:US USD 1.63B 1.22M
Peregrine Pharmaceuticals PPHM:US USD 451.22M 21.38M
Sangamo Biosciences SGMO:US USD 593.91M 23.21M
Smith & Nephew PLC SN/:LN 10.1B 815M
Stryker SYK:US USD 35.98B 49M
Surmodics SRDX:US USD 158.36M 17.29M
Veracyte VCYT:US USD 1.13B 18.24M
Xencor XNCR:US USD 835.27M 16.06M
Zimmer Biomet Holdings Inc ZBH:US USD 21.33B 119.4M